Infosys Limited Q2 FY26 Earnings Analysis

Published 29 May 2026 | IT Services | Market Cap: ₹52.8K Cr

Price

12.7

Market Cap

₹52.8K Cr

P/E Ratio

15.1

Revenue Rank

Rank 4

Margin Rank

Rank 3

Earnings Summary

- Revenue growth guidance for FY ’27 is between 1.5% to 3.5% in constant currency terms. - FY ’27 revenue growth guidance is 1.5% to 3.5% year-on-year in constant currency terms, reflecting a cautious but positive outlook.

📊 Revenue & Sales Performance

Rank 4

- Revenue growth guidance for FY ’27 is between 1.5% to 3.5% in constant currency terms. - Expect acceleration in growth specifically in Financial Services and Energy Utilities Resources Services verticals. - H1 of FY ’27 expected to be stronger than H2, consistent with normal seasonality. - Volumes for FY ’26 were flattish; for FY ’27, volumes expected to remain flat or marginally positive. - Growth driven by AI services, large deal wins (55% net new deals in FY ’26 totaling $15 billion), and expanded client footprint. - Deflationary impact from productivity gains and on-site mix reduction expected to continue, partially offset by AI-driven new services growth. - Pricing realization improved in FY ’26 supported by AI value, helping maintain margins despite competitive intensity. - Headcount growth planned with 20,000 freshers to be hired in FY ’27 to support service delivery and growth initiatives.

📈 Profitability & Margins

Rank 3

- FY ’27 revenue growth guidance is 1.5% to 3.5% year-on-year in constant currency terms, reflecting a cautious but positive outlook. - Operating margin guidance for FY ’27 is 20% to 22%, factoring in headwinds from wage hikes, productivity pass-throughs, and AI investments, offset by Project Maximus initiatives. - Large deal pipeline remains strong with 55% net new deals contributing to expected growth acceleration in FY ’27. - EPS adjusted for income tax and other factors grew double digits in FY ’26; with stable margins, further improvement expected but moderated by market conditions. - Growth drivers include AI services, digital transformation, and strong partnerships in AI, balanced against some revenue compression due to productivity gains and on-site mix reduction. - Management anticipates a strong, successful year but notes potential variability due to macro environment and client discretionary spending.

🏗️ Capital Expenditure Plans

No information

The transcript does not explicitly detail specific current or future capex, capital investments, or strategic investments in exact figures or projects. However, key points related to investments mentioned include: - Continued investment in AI talent and AI capabilities, absorbing costs within margin guidance. - Increased sales and marketing investments (+40 basis points) to support growth initiatives. - Investment in partnerships with foundation model companies and AI tool companies. - Project Maximus driving productivity and value-based savings, indicating ongoing operational investment. - No specific mention of traditional capex; focus is on strategic investments in AI and human capital. - No visibility shared on JV and acquisitions (e.g., Optimum Healthcare acquisition yet to be closed). Overall, the company emphasizes strategic investments in AI, talent, sales, and operational efficiency to drive growth and margin maintenance.

💰 Fundraising & Capital Structure

No information

The transcript does not mention any current or future fundraising plans through debt or equity. Key points related to capital allocation and finances are: - The company has a strong cash generation capability with consolidated cash and investments at $4.5 billion after returning over $4 billion to shareholders in FY ’26. - The Board has proposed a final dividend of INR 25 per share, increasing total dividend by 11.6% over last year. - No mention of plans for raising new debt or equity funding. - Capital allocation policy appears focused on dividends and reinvestment in business (AI talent, sales, marketing, acquisitions). - The company closed some acquisitions recently but excluded some pending acquisitions from guidance, with no indication of associated fundraising. Thus, there is no indication from the provided transcript of any upcoming fundraising through debt or equity.

📋 Order Book & Pipeline

Yes

- Infosys signed $15 billion worth of large deals in FY '26, comprising 96 deals with 55% being net new. - The large deal pipeline remains strong going forward. - The company reported an increase in clients with contracts over $50 million (increased by 3) and over $100 million (increased by $400 million). - Despite a strong orderbook, organic growth guidance for FY '27 is 1.5% to 3.5% (constant currency), reflecting a balance of growth drivers and pricing pressures. - Net new deals, while robust, came in at the lowest level seen in recent years, but renewal deals remain healthy and contribute to overall orderbook stability. - Management remains confident with a solid large deal pipeline and expects growth from the AI services segment and other growth drivers.

Key Metrics

Revenue

Rank 4

Margin

Rank 3

Capex

No information

Fundraise

No information

Order Book

Yes

Frequently Asked Questions

What were Infosys Limited Q2 FY26 results?

- Revenue growth guidance for FY ’27 is between 1.5% to 3.5% in constant currency terms. - FY ’27 revenue growth guidance is 1.5% to 3.5% year-on-year in constant currency terms, reflecting a cautious but positive outlook.

What is Infosys Limited share price analysis?

Infosys Limited currently shows a neutral. The stock trades at a P/E of 15.1 with a market cap of $52,759. Investors should review the full earnings analysis for detailed insights.

Is Infosys Limited planning capital expenditure?

The transcript does not explicitly detail specific current or future capex, capital investments, or strategic investments in exact figures or projects.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.